Skip to main content

Funicular Fund, LP's Form 4 filing

Oruka Therapeutics, Inc. (ORKA) · filed May 9, 2022

Accession no.
0000921895-22-001519
Filed
May 9, 2022, 5:44 PM ET
Trade date
May 5-9, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $282.6K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Funicular Fund, LPCIK 0001752618Other: See Footnote 1
Ma-Weaver JacobCIK 0001922140Other: See Footnote 1

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 5, 2022Common StockPPurchaseAcquired+16,903$2.27+$38,449.252,244,487Direct
May 6, 2022Common StockPPurchaseAcquired+57,998$2.28+$132,392.032,302,485Direct
May 9, 2022Common StockPPurchaseAcquired+49,221$2.27+$111,721.832,351,706Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)